Table 4.
Site of GI bleeding | Rivaroxaban (n) | Warfarin (n) |
---|---|---|
Upper GI tract | (a) Distal esophageal ulcer with friable ulcer (1) (b) Gastric ulcer (1) (c) Esophageal varices (1) |
(a) PUD (2) (b) AVM in stomach/duodenum (3) (c) Sphincterotomy site after ERCP (1) (d) Scopes were not performed (1)‡ |
| ||
Lower GI tract | (a) Rectal cancer (1) (b) Internal hemorrhoids (1) (c) Internal hemorrhoids with diverticulosis and multiple colonic polyps (1) (d) Sigmoid ulcers (1) |
(a) Colon cancer (2) (b) Internal hemorrhoids (c) Large cecal polyp (1) (d) Scopes were not performed (1)∗ |
| ||
Occult GI bleeding | None | EGD/colonoscopy/push enteroscopy were negative (4) |
AVM: arteriovenous malformation, EGD: esophagogastroduodenoscopy, ERCP: endoscopic retrograde cholangiopancreatography, and PUD: peptic ulcer disease. ‡Patient had hematemesis which indicated upper GI bleeding, but scopes were not performed because of patient's refusal. ∗Patient had bright red blood per rectum which indicated lower GI bleeding in the clinical scenario, but scopes were not performed because of patient's refusal.